ArriVent BioPharma, Inc. Common Stock
A$40.18
AUD
Last updated on --.
24h volume13.11K
24h highest40.3174 AUD
24h lowest38.8816 AUD
24h Price movement+2.58%
AVBP recent prices
24 Hours
+2.58%+A$1.009
30 days
-7.85%-A$3.337
60 days
+24.73%+A$7.431
90 days
+20.32%+A$6.617
Key data
Previous close39.1747 AUD
Market cap1.78B AUD
Volume13.11K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-4.3746 AUD
Net income (FY)-203.64M AUD
Revenue (FY)--
Last report dateMay 11, 2026
About ArriVent BioPharma, Inc. Common Stock
HeadquartersNEWTOWN SQUARE
Employees (FY)77.00
Net income per employee (FY)-2.64M AUD
Listed onNasdaq
AVBP conversion tables
 |  |
|---|---|
| 0.5 AVBP | 20.09 AUD |
| 1 AVBP | 40.18 AUD |
| 5 AVBP | 200.92 AUD |
| 10 AVBP | 401.84 AUD |
| |
|---|---|
| 0.5 AUD | 0.012443 AVBP |
| 1 AUD | 0.024885 AVBP |
| 5 AUD | 0.12443 AVBP |
| 10 AUD | 0.24885 AVBP |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
AVBP is trading at A$40.18, +2.58% over the last 24 hours. Track live moves on the price chart at the top of this page.
The AVBP stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AVBP is currently trading at A$40.18, +2.58% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AVBP price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AVBP's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AVBP; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AVBP's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
ArriVent BioPharma, Inc. Common Stock's market cap is currently 1.78B AUD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume13.11K
24h highest40.3174 AUD
24h lowest38.8816 AUD
24h Price movement+2.58%
Start trade with AVBP Perpetual
Sign up to trade